ALN-F1202: Safety Study in Healthy Adults

We are testing a new treatment called ALN-F1202 to see if it is safe and well-tolerated in healthy adults. This study is important for future research on its use in patients.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
UZ Leuven
Clinical Pharmacology & Therapeutics
Heverlee, Belgium
Sponsor: Regeneron Pharmaceuticals Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.